Clariant AG/Fr. CLN
1D1W1MYTD1Y5YMAX
Capital at risk
About Clariant AG
Clariant AG is a multinational specialty chemicals company headquartered in Muttenz, Switzerland. The company operates in various segments, including Care Chemicals, Catalysts, and Natural Resources. Clariant provides a wide range of products such as industrial and consumer specialties, oil and mining services, and functional minerals. Founded in 1995 as a spin-off from Sandoz, Clariant has developed a global presence, serving diverse industries like personal care, agriculture, and energy. It emphasizes innovation and sustainability in its product offerings, leveraging its expertise to cater to complex chemical requirements across different markets.
- Ticker
- Fr. CLN
- Sector
- Materials
- Primary listing
- XSWX
- Employees
- 10,107
- Headquarters
- Muttenz, Switzerland
- Website
- www.clariant.com
Clariant AG Metrics
BasicAdvanced
CHF 3.5B
-
-CHF 0.10
0.45
CHF 0.42
3.98%
Price and volume
Market cap
CHF 3.5B
Beta
0.45
52-week high
CHF 11.04
52-week low
CHF 6.55
Average daily volume
739K
Dividend rate
CHF 0.42
Financial strength
Current ratio
1.77
Quick ratio
0.954
Long term debt to equity
0.826
Total debt to equity
0.977
Interest coverage (TTM)
6.02%
Profitability
EBITDA (TTM)
564.9
Gross margin (TTM)
30.98%
Net profit margin (TTM)
-0.82%
Operating margin (TTM)
9.58%
Effective tax rate (TTM)
100.22%
Revenue per employee (TTM)
CHF 380,000
Management effectiveness
Return on assets (TTM)
3.83%
Return on equity (TTM)
-0.01%
Valuation
Price to revenue (TTM)
0.916
Price to book
1.72
Price to tangible book (TTM)
6.32
Price to free cash flow (TTM)
10.161
Free cash flow yield (TTM)
9.84%
Free cash flow per share (TTM)
1.039
Dividend yield (TTM)
3.98%
Growth
Revenue change (TTM)
-6.62%
Earnings per share change (TTM)
-129.44%
3-year revenue growth (CAGR)
-8.30%
10-year revenue growth (CAGR)
-4.21%
3-year earnings per share growth (CAGR)
-24.31%
10-year earnings per share growth (CAGR)
-17.25%
10-year dividend per share growth (CAGR)
0.49%
What the Analysts think about Clariant AG
Analyst ratings (Buy, Hold, Sell) for Clariant AG stock.
Analyst projections of the future price of Clariant AG stock.
Bulls say / Bears say
Clariant’s pricing discipline and cost programme are protecting profitability despite weak volumes. Q2 EBITDA before exceptional items rose 1.5% and the margin improved to 18.2%, while run-rate savings are now expected to reach CHF90 million in 2026 and CHF100 million by 2027. (Clariant)
Catalysts remain a major near-term weakness. Q2 sales fell 13.3% in local currency and volumes dropped 14.2%, with the Middle East conflict delaying orders; management expects Catalysts sales to remain below 2025 levels. (Clariant)
The company still carries a legacy legal overhang. Although an Amsterdam court dismissed Shell’s damages claim, Clariant said related proceedings in the Netherlands and Germany remain ongoing, so the litigation risk has been reduced rather than eliminated. (Clariant)
Data summarised monthly by Lightyear AI. Last updated on 19 Sept 2026.
Clariant AG Financial Performance
Revenues and expenses
Clariant AG Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing Clariant AG
AllUSDEURGBP
Fund name | Fund size | Fr. CLN weighting |
|---|---|---|
iShares MSCI World Small Cap$WSML | $9B | 0.03% |
iShares MSCI World Small Cap€IUSN | €7.8B | 0.03% |
iShares MSCI World Small Cap£WLDS | £6.7B | 0.03% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.